GlassScriptPhysician profile
Moneer J Eddin
NPI 1073780938
$17,124.06
in general payments reported to CMS, 2019-2025
44 companies · $6,594 in 2025
The $6,594 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,091 · 2020: $1,654 · 2021: $1,837 · 2022: $1,360 · 2023: $1,398 · 2024: $2,190 · 2025: $6,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,452 · Travel and Lodging: $3,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,451.63 |
| Travel and Lodging | $3,730.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,442.05 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $2,950.66 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Medtronic, INC. | $2,020.00 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Corevalve Evolut R |
| Abbott Laboratories | $1,365.25 | 2021-2025 | Triclip, Jot Dx, Amplatzer Amulet |
| Amgen INC. | $868.13 | 2019-2023 | Repatha |
| Abiomed | $830.80 | 2019-2025 | Impella |
| Boston Scientific Corporation | $746.48 | 2020-2025 | Watchman Flx, Watchman Access System, Varithena Administration Pack |
| Merck Sharp & Dohme LLC | $739.77 | 2021-2025 | Verquvo, Belsomra, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $461.40 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Pfizer INC. | $458.94 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $309.00 | 2019-2024 | Onpattro, Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $295.26 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.61 | 2019-2025 | Jardiance |
| Irhythm Technologies, INC. | $184.72 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $101.33 | 2024 | Arcalyst |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moneer Eddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.